In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis.
The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.
